Literature DB >> 29328794

Corneal abrasion following anaesthesia for non-ocular surgical procedures: A case-controlled study.

Anais L Carniciu1, Melissa J Fazzari2, Pauline Tabibian3, Priti Batta4, Ronald C Gentile4, James H Grendell5, Collin E Braithwaite6, Nazanin Barzideh4.   

Abstract

The aim of this study was to identify risk factors associated with perioperative corneal abrasion at a single hospital in Mineola, New York (United States). A chart review was conducted of patients with perioperative corneal abrasion following non-ocular surgery and age-matched controls between June 2011 and November 2013. An age-stratified logistic regression model evaluated the association between corneal abrasion and potentially predisposing variables. The adjusted odds of a corneal abrasion occurring were 4.6 times greater for patients having surgery for ≥ 3 hours (p=0.001) and 3.6 times greater for patients with pre-existing ocular disease (p=0.02). Gender, diabetes status, surgical procedure or position were not found to be associated with the occurrence of a corneal abrasion. Corneal abrasions were associated with longer procedures and history of pre-existing ocular disease. No significant association between body positioning or surgical site and perioperative corneal abrasion was found. The study concludes that a longer duration of surgical procedure and pre-existing ocular disease are risk factors for perioperative corneal abrasion. Copyright the Association for Perioperative Practice.

Entities:  

Keywords:  Complications; Corneal abrasion; Eye injury; Perioperative

Mesh:

Year:  2017        PMID: 29328794     DOI: 10.1177/175045891702701102

Source DB:  PubMed          Journal:  J Perioper Pract        ISSN: 1750-4589


  1 in total

1.  Exposure keratopathy and its associated risk factors in patients undergoing general anesthesia in nonocular surgeries.

Authors:  Nazanin Amini; Korosh Rezaei; Hesameddin Modir; Rezvan Kazemi Majd; Neda Graminejad; Fatemeh Rafiei; Reza Rezaei; Zohreh Davoodabady; Akram Bayati
Journal:  Oman J Ophthalmol       Date:  2022-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.